Annual Shareholders Equity
$3.17 M
-$9.84 M-75.65%
December 31, 2023
Summary
- As of February 7, 2025, OGEN annual stockholders equity is $3.17 million, with the most recent change of -$9.84 million (-75.65%) on December 31, 2023.
- During the last 3 years, OGEN annual shareholders equity has fallen by -$13.68 million (-81.19%).
- OGEN annual shareholders equity is now -88.04% below its all-time high of $26.49 million, reached on December 31, 2021.
Performance
OGEN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.08 M
+$1.75 M+132.03%
September 30, 2024
Summary
- As of February 7, 2025, OGEN quarterly stockholders equity is $3.08 million, with the most recent change of +$1.75 million (+132.03%) on September 30, 2024.
- Over the past year, OGEN quarterly shareholders equity has dropped by -$90.60 thousand (-2.86%).
- OGEN quarterly shareholders equity is now -91.46% below its all-time high of $36.05 million, reached on March 31, 2021.
Performance
OGEN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OGEN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.7% | -2.9% |
| 3 y3 years | -81.2% | -2.9% |
| 5 y5 years | -84.8% | -2.9% |
OGEN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | at low | -88.4% | +132.0% |
| 5 y | 5-year | -88.0% | at low | -91.5% | +132.0% |
| alltime | all time | -88.0% | +138.7% | -91.5% | +137.6% |
Oragenics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.08 M(+132.0%) |
| Jun 2024 | - | $1.33 M(-49.5%) |
| Mar 2024 | - | $2.63 M(-17.1%) |
| Dec 2023 | $3.17 M(-75.6%) | $3.17 M(-51.2%) |
| Sep 2023 | - | $6.50 M(-10.5%) |
| Jun 2023 | - | $7.26 M(-29.2%) |
| Mar 2023 | - | $10.24 M(-21.3%) |
| Dec 2022 | $13.01 M(-50.9%) | $13.01 M(-2.5%) |
| Sep 2022 | - | $13.34 M(-20.5%) |
| Jun 2022 | - | $16.79 M(-18.3%) |
| Mar 2022 | - | $20.54 M(-22.4%) |
| Dec 2021 | $26.49 M(+57.2%) | $26.49 M(-7.2%) |
| Sep 2021 | - | $28.55 M(-12.8%) |
| Jun 2021 | - | $32.73 M(-9.2%) |
| Mar 2021 | - | $36.05 M(+114.0%) |
| Dec 2020 | $16.84 M(-2.2%) | $16.84 M(+74.7%) |
| Sep 2020 | - | $9.64 M(+9.7%) |
| Jun 2020 | - | $8.79 M(-31.9%) |
| Mar 2020 | - | $12.91 M(-25.1%) |
| Dec 2019 | $17.23 M(-17.5%) | $17.23 M(-17.2%) |
| Sep 2019 | - | $20.82 M(-14.8%) |
| Jun 2019 | - | $24.42 M(-16.1%) |
| Mar 2019 | - | $29.12 M(+39.5%) |
| Dec 2018 | $20.88 M(+230.6%) | $20.88 M(+49.4%) |
| Sep 2018 | - | $13.98 M(+282.9%) |
| Jun 2018 | - | $3.65 M(-15.4%) |
| Mar 2018 | - | $4.32 M(-31.7%) |
| Dec 2017 | $6.32 M(+113.0%) | $6.32 M(+523.5%) |
| Sep 2017 | - | $1.01 M(+100.4%) |
| Jun 2017 | - | $505.50 K(-57.4%) |
| Mar 2017 | - | $1.19 M(-60.0%) |
| Dec 2016 | $2.97 M(-37.3%) | $2.97 M(-33.9%) |
| Sep 2016 | - | $4.49 M(-14.4%) |
| Jun 2016 | - | $5.24 M(+82.3%) |
| Mar 2016 | - | $2.87 M(-39.3%) |
| Dec 2015 | $4.73 M(-54.2%) | $4.73 M(+214.7%) |
| Sep 2015 | - | $1.50 M(-51.4%) |
| Jun 2015 | - | $3.09 M(-66.2%) |
| Mar 2015 | - | $9.16 M(-11.4%) |
| Dec 2014 | $10.34 M(-34.7%) | $10.34 M(-10.6%) |
| Sep 2014 | - | $11.56 M(-7.9%) |
| Jun 2014 | - | $12.56 M(-11.6%) |
| Mar 2014 | - | $14.20 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $15.84 M(+71.6%) | $15.84 M(+263.1%) |
| Sep 2013 | - | $4.36 M(-23.2%) |
| Jun 2013 | - | $5.68 M(-25.7%) |
| Mar 2013 | - | $7.65 M(-17.1%) |
| Dec 2012 | $9.23 M(-212.9%) | $9.23 M(-14.8%) |
| Sep 2012 | - | $10.83 M(-847.7%) |
| Jun 2012 | - | -$1.45 M(+360.9%) |
| Mar 2012 | - | -$314.30 K(-96.2%) |
| Dec 2011 | -$8.18 M(+330.6%) | -$8.18 M(+24.3%) |
| Sep 2011 | - | -$6.58 M(+32.0%) |
| Jun 2011 | - | -$4.99 M(+49.3%) |
| Mar 2011 | - | -$3.34 M(+75.8%) |
| Dec 2010 | -$1.90 M(-172.0%) | -$1.90 M(-1181.6%) |
| Sep 2010 | - | $175.60 K(-314.9%) |
| Jun 2010 | - | -$81.70 K(-105.1%) |
| Mar 2010 | - | $1.59 M(-39.9%) |
| Dec 2009 | $2.64 M(-1589.6%) | $2.64 M(-395.6%) |
| Sep 2009 | - | -$893.10 K(-30.6%) |
| Jun 2009 | - | -$1.29 M(-39.8%) |
| Mar 2009 | - | -$2.14 M(+1106.9%) |
| Dec 2008 | -$177.20 K(-121.6%) | -$177.20 K(-106.3%) |
| Sep 2008 | - | $2.79 M(-28.4%) |
| Jun 2008 | - | $3.90 M(+80.9%) |
| Mar 2008 | - | $2.16 M(+162.9%) |
| Dec 2007 | $819.90 K(-35.9%) | $819.90 K(-44.9%) |
| Sep 2007 | - | $1.49 M(+114.1%) |
| Jun 2007 | - | $694.50 K(-43.6%) |
| Mar 2007 | - | $1.23 M(-3.8%) |
| Dec 2006 | $1.28 M(-27.8%) | $1.28 M(+11.6%) |
| Sep 2006 | - | $1.15 M(-27.0%) |
| Jun 2006 | - | $1.57 M(+2.1%) |
| Mar 2006 | - | $1.54 M(-13.2%) |
| Dec 2005 | $1.77 M(-56.1%) | $1.77 M(+27.3%) |
| Sep 2005 | - | $1.39 M(-39.1%) |
| Jun 2005 | - | $2.28 M(-22.9%) |
| Mar 2005 | - | $2.96 M(-26.7%) |
| Dec 2004 | $4.04 M(+17.3%) | $4.04 M(-9.9%) |
| Sep 2004 | - | $4.48 M(-13.1%) |
| Jun 2004 | - | $5.16 M(-12.4%) |
| Mar 2004 | - | $5.89 M(+71.3%) |
| Dec 2003 | $3.44 M | $3.44 M(+117.1%) |
| Sep 2003 | - | $1.58 M(-1.2%) |
| Jun 2003 | - | $1.60 M |
FAQ
- What is Oragenics annual stockholders equity?
- What is the all time high annual shareholders equity for Oragenics?
- What is Oragenics annual shareholders equity year-on-year change?
- What is Oragenics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Oragenics?
- What is Oragenics quarterly shareholders equity year-on-year change?
What is Oragenics annual stockholders equity?
The current annual shareholders equity of OGEN is $3.17 M
What is the all time high annual shareholders equity for Oragenics?
Oragenics all-time high annual stockholders equity is $26.49 M
What is Oragenics annual shareholders equity year-on-year change?
Over the past year, OGEN annual stockholders equity has changed by -$9.84 M (-75.65%)
What is Oragenics quarterly stockholders equity?
The current quarterly shareholders equity of OGEN is $3.08 M
What is the all time high quarterly shareholders equity for Oragenics?
Oragenics all-time high quarterly stockholders equity is $36.05 M
What is Oragenics quarterly shareholders equity year-on-year change?
Over the past year, OGEN quarterly stockholders equity has changed by -$90.60 K (-2.86%)